120
Participants
Start Date
August 31, 2011
Primary Completion Date
November 30, 2013
Study Completion Date
April 30, 2014
Tocilizumab 280 mg
Intravenous administration of 280 mg Tocilizumab (14 ml), mixed with 86 ml 0.9% NaCl
NaCl 0.9% 100 ml
Placebo
St Olavs Hospital, Trondheim
Oslo University Hospital, Oslo
St. Olavs Hospital
OTHER
South-Eastern Norway Regional Health Authority
OTHER
University of Oslo
OTHER
Norwegian University of Science and Technology
OTHER
Oslo University Hospital
OTHER